OCM
INSM icon

Osbon Capital Management’s Insmed INSM Stock Holding History

Osbon Capital Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.4K Hold
137
– – 0.02% 221
2025
Q4 		$23.8K Buy
+137
New +$25K 0.02% 172

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Osbon Capital Management's INSM Position: Q1 2026 in Review

Osbon Capital Management held its Insmed (INSM) position steady in Q1 2026 at 137 shares worth $22.4K. The position accounts for 0.02% of the portfolio, ranked #221.

Osbon Capital Management first reported a position in INSM in Q4 2025 and has held it in 2 quarters since. The position peaked at $23.8K in Q4 2025. 670 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Osbon Capital Management held 137 shares of Insmed worth $22.4K as of Q1 2026.
  • Osbon Capital Management left its Insmed share count unchanged in Q1 2026.
  • Insmed made up 0.02% of Osbon Capital Management's portfolio in Q1 2026, its #221 holding.
  • Osbon Capital Management first reported a position in Insmed in Q4 2025 and has held it in 2 quarters since.
  • Osbon Capital Management's Insmed position peaked at $23.8K in Q4 2025.
  • 670 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Osbon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.